IL6 and atherosclerosis: Atherosclerosis progression, as a chronic inflammatory mechanism, is characterized by immune system dysregulation associated with increased pro-inflammatory cytokine production, including interleukin 6 (IL-6), tumor necrosis factor-α (TNF-α), and IL-1β, as well as pattern recognition receptor proteins like CRP (170, 261–267).